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STRUCTURED ABSTRACT
Study design: Literature review
Objective: To critically review all publications/internet sites that have described/used the
Walking Index for Spinal Cord Injury (WISCI II), as a measure of impairment of walking
function after spinal cord injury (SCI), in order to identify its psychometric properties,
clarify its nature, specify misuse, and incorporate the findings in an updated guide.
Method: A systematic literature search was done of Ovid MEDLINE, CINAHL,
PsychINFO, Cochrane Central Register of Controlled Trials, Scopus, and electronic sites
using key words: WISCI or WISCI II, SCI, paraplegia/ tetraplegia/ quadriplegia,
ambulation/gait/walking. Among 1,235 citations retrieved, 154 relevant articles/sites
were identified, classified and examined by the authors; recommendations were made
based on findings.
Results and Discussion: The validity
(face/concurrent/content/construct/convergent/criterion) and reliability of the WISCI II
has been documented in clinical trials, clinical series, and considered adequate by
systematic reviewers. In chronic SCI subjects, reliable determination of the maximum (as
opposed to self-selected) WISCI II level requires more time and experience by the
assessor. The correct use of WISCI II is clarified for testing acute/chronic phases of
recovery after SCI, age of subjects, devices and settings. The WISCI II and walking
speed measures may be performed simultaneously.
Conclusion: The increased use of the WISCI II is attributed to its unique characteristics
as a capacity measure of walking function and its strong metric properties. Appropriate
use of the WISCI II was clarified and incorporated into a new guide for its use.
Combining it with a walking speed measure needs further study.
Sponsorship: This study was supported in part by grant #H133N000023 from the
National Institute on Disability and Rehabilitation Research (NIDRR), Office of Special
Education and Rehabilitative Services (OSERS), U.S. Department of Education,
Washington, DC.
Keywords: Walking Function, WISCI, Spinal Cord Injury, Outcome Measure,
Functional Capacity Scale
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INTRODUCTION
The Walking Index for Spinal Cord Injury (WISCI) is an ordinal scale that captures the extent and

3

nature of assistance (combinations of orthoses, supporting equipment such as walkers, and human

4

helpers) that persons with spinal cord injury (SCI) require to walk. The original 19 levels, from unable to

5

walk in spite of all possible supports, to being able to walk without any, were rank-ordered by a panel of

6

SCI experts to reflect gradations of impairment and their relationship to walking function.1 The WISCI

7

scale was modified the following year to the WISCI II with the addition of two levels.2 Since its

8

introduction, it has enjoyed increased popularity3 and acceptance4 as a capacity measure of walking

9

function for use in clinical trials.

10

International SCI experts5,6 have, however, recommended that the WISCI II,2 be combined with

11

the Ten Meter Walk Test (10MWT), another validated tool for quantifying walking function. Systematic

12

reviews of the medical literature confirm the validity of the WISCI/WISCI II7 and its use together with

13

the 10 MWT for assessment of ambulatory function.8

14

It has been recommended by some, nonetheless, that the WISCI II undergo further evaluation.6,7,9

15

Recent studies10-12 have demonstrated reliability, and the relationship of WISCI II to both the severity of

16

the injury and to walking speed. These studies also showed the need to progress subjects

17

systematically10,11 from their community (self selected) WISCI II level (performance, in the terminology

18

of the International Classification of Functioning, Disability and Health (ICF)13 to their maximum level

19

(capacity, in ICF terms), which has not been clearly stated in existing instructions to clinical

20

investigators14-16 and does require additional time, and training for obtaining accurate assessments.

21

Our purpose here is to critically review all publications and internet sites that have described

22

and/or used the WISCI/WISCI II, in order to identify and clarify the nature, psychometric properties,

23

correct use and misuse of the WISCI II. Recommendations for proper use, stemming from this review,

2

24

are incorporated into an updated guide (Appendix 1: WISCI II Guide: Instructions for Use) suitable for

25

use by clinical investigators and dissemination in the literature and appropriate websites.17

26
27
28

METHOD
A systematic search was performed of all papers as well as websites mentioning WISCI/WISCI II.

29

The literature search was conducted with the assistance of a senior librarian from May to August, 2011

30

and identified papers published from 2000 to August 2011 that explicitly mentioned the WISCI/WISCI II,

31

and/or articles that dealt with the measurement of walking capacity in patients with SCI. Databases

32

included Ovid MEDLINE, Ovid MEDLINE In-Process & Other Non-Indexed Citations, CINAHL,

33

PsychINFO, Cochrane Central Register of Controlled Trials, and Scopus, which includes Embase

34

citations. All study designs, including case reports, were included, with no restrictions on the ages of

35

participants. Non-English articles and animal studies were excluded. The following search terms were

36

used: WISCI/WISCI II, SCI, paraplegia/tetraplegia/quadriplegia, ambulation/gait and walking/walking

37

capacity. Citations were then imported into a RefWorks© database and duplicates removed, leaving

38

1,235. In addition, other data bases such as Google and a hand search of Spinal Cord yielded twelve

39

citations not identified by the above strategy.

40

Two authors (GS & JFD) independently identified and classified the papers and (as applicable)

41

their study design, which included both SCI and WISCI/WISCI II through a review of the abstracts, texts

42

and references. A third author (PLD) reconciled differences and prepared results for circulation to the

43

authors’ panel and subsequently to external reviewers. This yielded 168 citations from all sources, of

44

which 14 were subsequently excluded as non-English, involving diseases other than SCI or animal

45

research, for a total of 154 relevant references.

3

46

The list of 154 citations with their assigned classification is published as supplementary material.

47

Sixteen of the 154 study citations examined underlying mechanisms of physiological changes and

48

referenced the WISCI II scale. Ten of these 16 studies correlated changes in WISCI II scores with

49

neurophysiological parameters, whereas 6 cited the WISCI/WISCI II only in the bibliography or for

50

purposes of classification of the subjects.

51

Relevant citations included six systematic reviews of outcome measures for SCI, which referenced

52

WISCI/WISCI II. Two reviews 7,8 assessed the validity and other psychometric properties of outcome

53

measures for ambulation, including the WISCI II. Other reviews targeted measures of disability,18

54

general function or mobility19 or merely reference the WISCI II in studies on body weight

55

supported/robot-assisted gait training.20,21 Articles7, 9 that identified limitations of the WISCI/WISCI II

56

were studied carefully for issues related to the WISCI/WISCI II requiring clarification. Afterwards, the

57

guide for suggested future use of the WISCI II was edited by a coauthor (MSR) who has trained clinical

58

investigators in previous clinical trials in Asia, Europe and USA. The final guide was reviewed by the

59

panel of authors and by outside reviewers for comment and approval. The outside reviewers were chosen

60

to provide balance and reduce bias; Tania Lam and Hubertus van Hedel, who had published most of

61

criticisms7,30 discussed in this manuscript.

62

A panel composed of authors of the WISCI/WISCI II identified the following issues for further

63

analysis and discussion: the nature of the WISCI/WISCI II, the relationship of severity of injury to

64

walking capacity, the validity, reliability and responsiveness of the scale and its correct use (see below).

65
66

RESULTS AND DISCUSSION

67

1. Nature of the WISCI II

4

68

The WISCI II is unique as a walking capacity scale for individuals with SCI who have the

69

capacity “to stand and walk,” for several reasons. First, it has standard criteria for the testing environment

70

and subjects are progressed systematically through a validated sequence of capacity levels,22 incorporating

71

devices and personal assistance, to their maximum walking capacity. Second, WISCI II ranks levels

72

according to the severity of underlying impairment rather than the need for physical assistance, walking

73

aids, or braces (or their equivalent). The relationship between the severity of the impairment, reflected in

74

the strength of leg muscles (lower extremity motor scores), and the WISCI II has been demonstrated in

75

acute23 and chronic11 subjects with SCI. In fact, in subjects with acute SCI, the initial (baseline) lower

76

extremity motor score (LEMS) is the best predictor of WISCI II score at 12 months post SCI onset,

77

explains most of the variance in the WISCI II, and has high correlations with WISCI II improvement at 3,

78

6, 9 and 12 months.23 The strength of these correlations differ based on whether subjects are paraplegic or

79

tetraplegic, the demographics of the population studied, and whether subjects have acute or chronic

80

injuries.11,24 Factors other than LEMS such as pain, spasticity or balance also contribute to walking

81

function. Training plays a major role in improvement in walking function for subjects with chronic SCI,

82

in whom leg strength has been maximized and plateaued.24

83

The WISCI II’s levels reflect the underlying impairment and should not be dichotomized into

84

dependent and independent levels based on physical assistance, in an attempt to more closely mirror a

85

disability scale. Its unique features differentiate the WISCI II from disability scales, which may fail to

86

identify differences in devices when assigning scores. As an example, the Functional Independence

87

Measure (FIM) assigns a 6 for locomotion to an individual capable of modified independent ambulation

88

regardless of the device(s) used; while the Spinal Cord Independence Measure (SCIM) progresses the

89

ranking of devices from walking frame to one cane without addressing personal assistance at each level as

90

discussed by Patrick.25
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91

The WISCI II scale is an impairment related capacity scale and the lower extremity motor score

92

explains most of the variance (R2 = 0.85) of the WISCI score at 12 months in a multicenter randomized

93

trial of 146 subjects.23 Capacity measures of walking function such as the WISCI II and walking speed

94

utilized in research studies require standardized measurements of devices, distance and the environment.

95

However, global disability scales (performance) such as the FIM reflect burden of care and describes what

96

a person routinely does in their environment,13 which “may differ from individual to individual and from

97

one time to another”.26 Curt27 reported significant functional improvement in activities of daily living at

98

12 months in 246 ASIA A and B subjects assessed by the SCIM (a global disability scale) with no change

99

in WISCI scores. This improvement is most likely due to training alone (i.e. compensation)27 since a

100

subject with complete paraplegia may achieve wheelchair independence with no recovery in lower

101

extremity strength. Thus, papers19,28 that identify the WISCI II as a disability scale place it in the incorrect

102

domain (ICF classification) and are in error.

103
104
105

Systematic progression justifies all WISCI II levels
In the original publications1, 2, the ranking of the 21 levels was determined and validated by SCI

106

specialists from 8 countries. Order was determined by the severity of the underlying motor impairment

107

which resulted in some WISCI II levels which require physical assistance but few devices (i.e. reflecting

108

less impairment) being placed higher than other levels where subjects ambulate without physical

109

assistance but more devices. This is one of the characteristics that distinguish the WISCI II as a capacity

110

scale from disability scales which always rank individuals who do not require human assistance higher,

111

regardless of the use of devices. Some publications29,30 noted that the observed frequency of some WISCI

112

II levels (14 and 17) was low and therefore they might not be needed. It was also noted that the WISCI II

6

113

instructions require clarification as to how to assess subjects’ walking capacity at follow-up after

114

discharge from the hospital.

115

While prior guides1,14 stated that during the acute period SCI subjects should be assessed at the

116

highest possible level without compromising safety, as determined by a trained therapist; the precise

117

method of systematic progression in chronic subjects has not been stated. Determining the maximum

118

WISCI II level requires that subjects be progressed systematically through each level; as several

119

studies10,11 have shown that the maximal level may be 3 to 6 levels higher than the patient’s self-selected

120

one. Marino’s study10 provides insight into how frequently WISCI II levels 14 and 17 are used during the

121

progression of subjects from their self selected to maximum WISCI II level. Over half (14/26) of subjects

122

progressed to or beyond level 14 during the determination of their maximal WISCI II level and almost a

123

quarter (6/26) progressed to 17 or above. However, only 2 of 26 ended their progress at levels 14 or 17.

124

In chronic subjects the challenge is ensuring that the maximum level has been accurately evaluated. This

125

method of progression for chronic subjects has been described in recent papers10, 11 and has been

126

incorporated into the updated guide.17

127
128

2. Psychometric qualities of the WISCI II

129

Validity

130

One of the strongest features of the WISCI II, which has likely contributed to its broad acceptance,

131

is high validity across multiple dimensions. The hierarchical ranking agreed on by the 24 experts in SCI

132

walking function established content and face validity.1, 2 A subsequent prospective study22 of 170

133

subjects in four countries confirmed that progression through the levels followed a monotonic pattern in

134

more than 80% of subjects, and the correlation of walking capacity (WISCI II) with impairment (LEMS)

135

was 0.91 (p< 0.001) at final assessment, supporting content and construct validity. Subsequent studies by

7

136

our group and others have demonstrated criterion-related, predictive and concurrent validity, as well as

137

both convergent and divergent construct validity.11,22,27,29,31,32 The outcomes of the Spinal Cord Injury

138

Locomotor Trial (SCILT)23 reported predictive, criterion and concurrent validity: the WISCI II was

139

correlated with LEMS (impairment), balance, walking speed, 6 minute walk (capacity), locomotor FIM (7

140

items) and the total motor FIM (13 items). Others studies have shown a correlation between the WISCI II

141

and mobility measures such as the 10MWT, Timed up and Go (TUG) test,31,33 6 minute walk test

142

(6MWT),32,34 Berg Balance Scale, SCIM and Spinal Cord Injury-Functional Ambulation Profile (SCI-

143

FAP).33

144
145

Reliability and responsiveness

146

Although the validity of the WISCI/WISCI II has been well established, it has been suggested that

147

further evidence of reliability and responsiveness is needed.6, 7,18,30 During the development of the WISCI

148

II, a videotape was created of representative patients functioning at each level (40 randomized clips) and

149

circulated to SCI experts. The data collected included 24 individual independent scorings and team

150

scorings. The inter-rater reliability (IRR) was 1.00 for individual participants and the 8 participating

151

teams.1 However, reliability here involved agreement on the nature and types of physical assistance and

152

aides the person used with walking.

153

A more crucial test for a capacity scale is whether two appropriately trained individuals agree on

154

the same level of maximum capacity after assessing and progressing the same patient independently. In a

155

study of subjects with chronic SCI, Marino and colleagues10 reported that inter-and intra-rater reliability

156

were both 1.00 for self selected WISCI II level. The intra-rater reliability for maximal level WISCI II was

157

1.00; inter-rater reliability was 0.98. The progression from self selected to maximal WISCI II level also

8

158

showed good agreement between and within therapists. Recently, Scivoletto12 reported that inter-rater

159

reliability was 0.98 for 19 acute patients.

160

The WISCI II was initially reported9 to have limited responsiveness in the period of 0-3 months

161

post SCI onset and poor responsiveness in subsequent periods, however, the study cohort was small (n =

162

22) and consisted of good walkers (70 % with LEMS ≥30). In a more representative sample of 886

163

persons with American Spinal Injury Association Impairment Scale (AIS) A, B, C and D injuries, the

164

same group reported several years later4 that responsiveness was good in AIS C (N=137) and D (N=223)

165

subjects, and equal to that of the 10MWT at 3, 6 and 12 months after injury.

166

In a study11 of 76 subjects with chronic SCI, WISCI II reproducibility was excellent, with an

167

intraclass correlation coefficient (ICC) of 0.99 for both the self-selected and maximum WISCI II level.

168

The resulting smallest real differences (SRDs) of 0.79 (self-selected) and 0.60 (maximum) suggest that “a

169

change of one WISCI II level can be interpreted as real in a chronic patient”.

170

The study of the psychometric properties of the WISCI II in chronic subjects has been limited to

171

an assessment of reliability, reproducibility and validity in two studies.10,11 Further validation in chronic

172

subjects is warranted.

173
174
175

3. Use and misuse of the WISCI II
Past criticisms of the WISCI II include ceiling effects,7, 23, 30 floor effects,7 lack of responsiveness

176

beyond 3 months,30 lack of clarity regarding the scoring of equivalents of short leg braces (e.g., Alpine

177

boots),3,30 broad range of physical assistance,30 redundant categories,30 and cultural differences in use of

178

walking devices. Several of these, such as responsiveness and low frequency (unneeded) categories, have

179

been addressed above.

9

180

The ceiling effect and other limitations of walking function were addressed in the original

181

publication1 by the statement “different distances (household and community), velocity and energy

182

requirements will need to be added”. Two studies demonstrating the ceiling effect were reported in 2006;

183

one with 22 subjects9 who were primarily AIS D, and the SCILT randomized controlled trial (RCT)23 of

184

144 patients, which included AIS B, C and D subjects. In both studies, the subjects who reached the

185

maximum WISCI II level of 20 were able to show improvement in the speed of walking in subsequent

186

evaluations. Ceiling effects were one of the reasons that studies examining subjects at different distances

187

and speeds were planned.10,11,35 Most authorities recommend combining the WISCI II with a measure of

188

walking speed to compensate for this shortcoming. The floor effect has been mentioned in one systematic

189

review,7 based on one study29 which included a large proportion (84/284) of AIS A SCI subjects. While

190

this study has value for demonstrating validity and providing normative data, the WISCI II was not

191

designed for AIS A subjects, as it was developed for subjects “who can stand and walk”.

192
193
194

Cultural issues
Cultural differences are an important consideration in planning a clinical trial and our group has

195

shown differences across cultures for both clinical approaches to walking training, and consumer

196

preferences for walking with SCI.25,36 For example, parallel bars are used far more frequently in Europe

197

than the USA,22 which reflects the therapists’ preference for equipment. This would change WISCI II

198

baseline scores if this equipment was unavailable or at least not tried. In the context of an international

199

trial, however, the effects of cultural differences are not limited to the types of walking aids and braces

200

used, but also result from differences in methods/intensities of therapy and dissimilar lengths of stay,

201

which may affect maximum WISCI II scores. Future multi-center studies across cultures (USA, Europe,

202

Asia) must consider this in the design and protocol.

10

203
204

Braces
The “grouping” of both short and long leg braces into one category “braces”3 and the variety of

205

alternatives to short leg braces such as “alpine boots” 30 has been raised as a problem when assigning

206

WISCI II levels.

207

Our prospective study22 showed that the “descriptors” for the different types of braces (short leg;

208

long leg, unilateral, bilateral), as listed in prior WISCI II publications1,2 and updated on the website,14,17

209

may be used to record the types of braces used as subjects progress to their maximum WISCI II Level.

210

The information on the type of brace does not alter the scoring of the WISCI II level. However, recording

211

the use of aids is extremely important information in the design of a trial, because of potential cultural

212

differences. Thus the use of descriptors is recommended in planning cross cultural trials (Appendix 1 –

213

WISCI II Guide: Instructions for Use).

214

This study revealed that the use of one (9%) or two (5%) long leg braces is far less common than

215

the use of short leg braces (28%).22 Therefore, adding separate WISCI II levels to reflect all the possible

216

brace combinations would result in a large increase in the number of levels, and does not seem warranted.

217

The criticism3 that advance reciprocating gait orthosis (ARGO) braces are not included needs

218

clarification. ARGO braces and other devices enable subjects with complete injuries to ambulate with a

219

spring loaded assist. Such mechanical devices could impact the correlation between an underlying motor

220

impairment and demonstrated walking capacity, and were never intended to be part of the WISCI II

221

assessment of SCI subjects who can “stand and walk”.

222

The descriptors (Appendix 1: WISCI II Guide: Instructions for Use) mentioned above are rarely

223

reported by those who study and utilize the WISCI II other than the WISCI/WISCI II authors

224

themselves.22 Based on these reports, several modifications of protocol language regarding walkers and

11

225

braces have been adopted14 since the original publication. Some of the web site descriptions15,16 of the

226

WISCI/WISCI II do not make mention of the expanded list of descriptors.

227
228

Physical Assistance

229

For the WISCI II levels that incorporate physical assistance, there is the potential for variability in

230

the extent of assistance provided. To provide additional clarification, the descriptors for specific amounts

231

of physical assistance have been provided on the WISCI II scoring sheet. Descriptors A1 (Max Assist x 2

232

people) and A2 (Min/Mod assist x 2 people) apply only to WISCI II levels 1 and 2, both of which require

233

maximal assistance. Descriptor A3 (Min/Mod assist x 1 person) applies to WISCI levels 3, 4, 6, 7, 8, 10,

234

11, 14 and 17. The Instructions for Use also clarify that any physical contact with the subject, including

235

“contact guarding” is considered physical assistance.

236
237

Use in Children

238

Although two of the web sites15, 16 are kept current and can be updated through communication

239

with the authors of the sites, there are several omissions/ inaccuracies, which have not been previously

240

addressed by the WISCI/WISCI II authors. The first has to do with the use of the WISCI II for children.

241

The psychometric properties (validity and reliability) of the WISCI II have not been evaluated for

242

children ages 13 to 21, as implied by Rehab Measures.16 A study will be reported in 2012 that examines

243

reliability in children.37

244
245
246
247

Qualifications of staff and time needed to administer the WISCI II
Another issue relates to the time required to perform the WISCI II test, where one site16 states “5
minutes” while the other15 has “a minimal time”. While this is accurate for the acute and sub-acute phases

12

248

of SCI, where therapists tend to know the capacity of their patients very well; recent studies in chronic

249

subjects, who were not known to their assessors,10,11,35 describe the need for progressive testing of WISCI

250

II levels from self selected (SS) to maximum (Max), which may require fifteen minutes. Since there often

251

is a difference of 3 to 6 levels between SS and Max, testing cannot be performed in five minutes

252

(Appendix 1 – WISCI II Guide: Instructions for Use).

253

Perhaps the issue that requires the greatest emphasis is the need for trained clinicians to perform

254

the WISCI II assessments. In the acute and sub-acute phases, the therapist must determine the maximum

255

WISCI II level and this requires a clinical judgment based on experience, because the subjects/patients are

256

not capable of making a reliable judgment on what the minimum support needed for walking is as they

257

begin to recover ambulatory function. After the patient is discharged to the community and returns for

258

assessment 3 to 12 months post injury, the preferred WISCI II level is by definition self-selected. At

259

times subjects have developed habits of walking without braces and with an unstable ankle; testing by a

260

trained clinician is required to determine the appropriate maximum WISCI II level, especially to make

261

judgments on patient safety that limit the maximum WISCI II.

262
263
264
265

4. Future Directions: Combining WISCI II with a Walking Speed Measure
Rationale
In exploring the reasons for combining the WISCI II with a measure of walking speed, we briefly

266

examine the characteristics of both, to demonstrate why each complements the other. The nature and

267

limitations of the WISCI II, particularly its ceiling effect, have been discussed above. Subjects with a less

268

severe initial injury may recover to the maximum WISCI II level of 20 within the first 3 months after SCI

269

and will no longer see improvement on the WISCI II,9, 23 therefore further improvement in walking

270

capacity requires assessing speed. Walking speed, however, has the limitation of a floor effect in clinical

13

271

trials, as illustrated in the SCILT trial.38 The baseline data38 for walking speed, measured for 50 feet in the

272

Dobkin trial, was assessed in less than 20% (20/142) of subjects; while all 142 subjects had baseline data

273

for the WISCI II (median = 1.49 and range 0-17). The walking speed for the 10 meter walk test

274

(10MWT) showed a floor effect30 in a large sample of 917 subjects, in which only 6 subjects were able to

275

complete the 10MWT and TUG at 2 weeks, compared to 74 at one month and 136 at 3 months. The

276

“flying start” or dynamic start of the 10MWT, as reported by van Hedel,30 requires subjects to walk a

277

minimum of 14 meters in order to assess the speed for the 10 middle meters which are timed, and very

278

few AIS C subjects are capable of this at 2 weeks. Upon examining the strengths and weaknesses of

279

walking speed measures and WISCI II, it seems logical to combine the two. Since the 10MWT can

280

demonstrate improvement in less severely paralyzed subjects at later stages of recovery when there is

281

often a ceiling for the WISCI II (level 20), and the WISCI II has far less of a floor effect at baseline

282

assessment, the two tests complement each other. This idea is shared in the literature,7,8,39 and an

283

international consensus conference on ambulation and gait6 recommended use of both measures in clinical

284

trials. Our systematic search of the literature reveals that a combination of the two measures is used not

285

only in clinical trials40 and case series,4,31 but has been used to validate other measures.33

286
287
288

Is it possible to administer both tests at the same time?
If it is recommended to acquire the data at the same time (i.e. during the same observed/timed10

289

meter walk), the use of a dynamic start is not possible for standardized WISCI II testing. While some

290

authors41 recommend a dynamic start with 2 meters of acceleration before measurement of walking speed,

291

others42 state that the static start with no acceleration is adequate. In a systematic review of walking

292

speed research in neurological diseases42 it was concluded that the static start is the preferred method for

293

the 10MWT. In addition, Scivoletto43 has shown that in chronic incomplete SCI patients, walking speed

14

294

with a static start does not differ significantly (P = 0.092) from walking with a dynamic start. Subjects

295

with the highest scores (WISCI II 18 – 20) and the lowest scores (WISCI II 9 – 12) showed no statistical

296

difference between the two methods and inter/intra rater reliability was .98-.99. Furthermore, Marino,10

297

Kim,35 and Burns11 have reported excellent correlations of walking speed measured using a static start

298

with WISCI II levels. Based on these recent studies, it appears that WISCI II and 10MWT may be

299

performed simultaneously, but this will need to be investigated in larger populations.

300
301

Is a combined scoring system for WISCI II and 10MWT possible?

302

A single score that encompasses the two most important agreed-upon elements of walking

303

capacity has tremendous research potential. The statistical method of blending the two metrics would be

304

the most challenging issue.

305

A recent study of walking function reported by Musselman et al.33 attempted to validate a new

306

measure which combines timed activities, use of devices and physical assistance into one metric. The

307

authors employed both the 10MWT and the WISCI II to validate their instrument, which has many

308

similarities to a combined 10MWT/WISCI II. The ordering of assistance, which combines walking aids

309

(walkers, crutches and canes) and physical assistance from one person, however, does not take into

310

account braces. It “encompasses the timed performance of 7 tasks, such as walking and negotiating

311

obstacles, doors, and stairs.” (p. 285), but not the walking capacity measured by the WISCI II or 10MWT,

312

and may serve as a complement to these measures in a trial. However, the combining of the WISCI II and

313

the 10MWT with timed activities would produce so many combinations and permutations that it is not

314

feasible.

315
316
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317
318

CONCLUSION
The increased use of the WISCI II may be attributed to its unique characteristics as a capacity

319

measure of walking function, its strong metric properties, and recommendations by international

320

panels.5,6,39 A systematic review of the literature found over 150 WISCI/WISCI II citations, including

321

clinical trials, cohort studies, case series, case reports, reviews and websites describing outcome measures.

322

Recent studies using the WISCI II have addressed concerns regarding the reliability of data resulting from

323

testing in chronic SCI subjects, where more time and experience by the assessor is required.

324

Misunderstandings and inappropriate use of the WISCI II scale revealed in this review of the literature

325

have required clarification and updating of the testing guide,17 which is published as an Appendix and will

326

be disseminated electronically. The major future challenge is enhancing the utility of the WISCI II by

327

combining it with a walking speed measure, in a statistically valid way.

328
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WISCI II Guide: Instructions for Use

Walking Index for Spinal Cord
Injury II (WISCI II) Guide:
Instructions for Use
Purpose

Subject
Selection

The WISCI/WISCI II scale was developed as a research tool in clinical
trials to measure improvements in walking in persons with acute and
chronic spinal cord injury.
NOTE: In a recent review of the literature (2012), it was found that
clinicians have misused the WISCI II scale by documenting WISCI II
levels on patients clinically, to show a more accurate snapshot of a
patient’s walking ability. The scale was not validated for this purpose.
However, if clinicians choose to assign a WISCI II level to a patient in a
clinical setting, they should clearly state whether the level is
baseline/self-selected or maximum (see below).

The following outline describes subjects for whom the scale is most
commonly utilized:
1. Spinal cord injury subjects who are capable of standing and walking
in parallel bars will be eligible for assessment. Only a reciprocal gait
(without the use of mechanical device ie ARGO) is to be considered
in scoring the WISCI II. Additional inclusion/exclusion criteria may
be necessary.
2. Most often ASIA Impairment Scale (AIS) grade A below T10 and AIS
B, C, and D subjects qualify (Ditunno 2004). AIS A subjects with a
higher injury level may be included in studies that use the WISCI II
but typically they would function on initial assessment at the 0 level.
3. Individuals with tetraplegia generally require motor strength in
triceps of at least grade 3 or better to be able to support their body
weight3,4. (Ditunno 2004, Dobkin 2003). Individuals with tetraplegia
and arm strength in triceps of less than grade 3 may not be easily
classified by the WISCI II scale (Ditunno, 2005).
4. The WISCI II has not been assessed for validity and reliability in
subjects under age 18.
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Standardized
Physical
Environment
and Distance

The WISCI II is a functional capacity scale, NOT a disability scale. It
must be used in a standardized environment with standardized
equipment and methods, which are observed and recorded by
professionals that are trained in the use of the WISCI II. The following
are necessary:
1. A flat, smooth, non-slippery surface of 10 meters length.
2. Individuals walk at their own speed.

Standardized
Physical
Assistance

Standardized
Equipment

Standardized
Method

1. Any physical contact with the subject, including “contact guarding”
is considered physical assistance.
2. Supervision without actual touching should not be regarded as
physical assistance.
3. For additional clarification, descriptors of specific levels of physical
assistance are provided on the WISCI II scoring sheet.

1. Walkers should be conventional, but if a rolling walker is used, it
should be coded as a walker and identified in the descriptors. A
rolling walker has commonly been used in the USA and several
European centers.
2. A platform walker is equivalent to a walker.
3. ARGOs and other mechanical devices (e.g. use of treadmills) should
be excluded.
4. Crutches can be Lofstrand (Canadian) or axillary.
5. “Braces” means one or two braces, either long or short, and should
be identified in the descriptors. Other devices used for bracing such
as ace wraps or splints should be coded as a brace and described
under “other”. Equivalents of short leg braces may include high top
“sneakers”; alpine shoes, or other footwear that stabilizes the ankle.
6. Whether long leg braces are locked or unlocked at the knees should
be identified in the descriptors.
7. Clothing should not cover braces to allow therapists and other
professional staff to make a visual determination that the patient
has a brace (Ditunno, 2005).

WISCI II testing is performed by physical therapists trained in the use of
the WISCI II, and baseline and maximum levels are determined
according to a specific protocol.
In the acute (hospital) setting, the initial (baseline) WISCI II level (i.e.,
the first one determined after injury onset) is determined by the
therapist alone, since the patient is newly injured and must be
instructed in achieving the maximum level that is safe in the hospital
setting under the supervision of the therapist
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In follow-up assessments after the patient has been discharged to a
community setting, the following steps are required to determine the
maximum WISCI II level.

Standardized
Method cont.

First, the therapist interviews the subject to determine the selfselected WISCI II level, which is defined as the level the subject is
ambulating at in the community, or in the household if the subject is
not a community ambulator. The therapist confirms that the
participant can ambulate 10 meters at the reported level. This is the
self-selected level, but may not be the maximum level.
To determine the maximum WISCI II level, the therapist advances the
subject sequentially through WISCI II levels starting at the level one
step above the self-selected level, until the subject fails a level or is
deemed unsafe for the next level. If the therapist thinks the subject can
ambulate three or more levels above the self-selected WISCI II level,
then to avoid fatigue, the subject can skip to a higher level. However, if
the subject fails to complete that level, the subject is tested at the first
skipped level and advanced until failure. If the level tested requires a
brace, an alternative method of ankle stabilization as described under
standardized equipment is acceptable.

Scoring

Time to
Administer

In scoring the WISCI II, first check the descriptors that apply to the
current walking performance, and then assign the level of walking
performance (see pgs. 7-8). For example, a subject who walks with a
rolling walker and assistance of one person and no braces would be
scored at a WISCI II Level 8. In selecting a level, one should choose the
level at which the patient is safe as judged by the therapist, with
patient’s comfort level described. If devices other than those stated in
the standard definitions are used, they should be documented in the
comment section. If there is a discrepancy between two observers
(that is, one judges the patient to be safe, the other unsafe; there
never should be disagreement as to whether the patient is or is not
using particular equipment; the patient’s comfort level is not of
relevance in assigning scores, unless insofar it informs on safety), the
higher level should be chosen.

The time needed to administer the WISCI II may vary from 5 minutes in
the acute phase to 15 minutes in a follow-up assessment. The duration
of the assessment depends on the subject’s self-selected WISCI II level
in the follow-up or chronic phase. For example, a subject who’s selfselected WISCI II is 19 may only take 5 minutes because he/she only
needs to be tested at 1 more level to reach his/her maximum WISCI II
level. Similarly, a subject whose self-selected WISCI II is at the lower
end of the scale may not be able to progress to a higher level and the
self-selected WISCI II and maximum WISCI II levels are the same.
Testing time for these two scenarios would be minimal. However,
those subjects who can progress through multiple WISCI II levels
beyond their self-selected level or require donning of additional
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equipment (such as braces), may take longer.

Additional Notes

In clinical trials initiated in the acute phase, the increase in score is
calculated by subtracting the baseline level at the beginning of the trial
from the maximum level at the end of the trial.
In performing the WISICI II, individuals walk at their own speed and the
10 meters should not be timed, unless the walking speed and the
WISCI II assessments are combined (Scivoletto 2011).
The WISCI II’s ranking of walking levels reflecting impairment should
not be dichotomized into dependent and independent levels of
physical assistance, in an attempt to more closely mirror a disability
scale.
Descriptors may have value in reflecting cultural differences when
planning a trial.
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Research
Face Validity

Twenty-four spinal cord injury (SCI) experts in walking function from
eight counties established and agreed on hierarchial ranking of 20
items. (Ditunno et al., 2000)
Results Kendall coefficient of concordance for the pilot data was significant
(W=0.843, P< 0.001) indicating agreement among the experts in rank
ordering of original items

Concurrent/
Predictive/
Construct Validity

First use of WISCI II in a clinical trial of Body-Weight Supported
Treadmill Training versus overground mobility training. Prospective
study of 146 subjects with incomplete SCI (C4 to L3) confirmed
concurrent validity of the WISCI by correlating with all measures at 3,
6, and 12 months. (FIM, 50-foot walking speed, 6-minute walk,
LEMS, Berg Balance, FIM Locomotor Score). Correlation of LEMS
change scores supports predictive validity (Ditunno et al., 2007).
Results - Correlations with WISCI at 6 months were significant with BBS (r =
.90), LEMS (r = .85), LFIM (r = .89), FIM (r = .77), 50FW-S (r = .85), and 6MWD (r = .79); similar correlations occurred at 3 and 12 months. Correlations of
change scores from baseline WISCI were significant for change scores from
baseline of LEMS/BBS/LFIM. Correlation of baseline LEMS and WISCI at 12
months were most significant (r = .73). The R2 of baseline LEMS explained

27
57% of variability of WISCI levels at 3 months.

Content/Construct
Prospective study of 170 subjects in four countries confirmed that
Validity

progression through the levels followed a monotonic pattern in
more than 80% of subjects and the relationship of walking capacity
(WISCI) to impairment (LEMS) was 91% (p< 0.001) at final
assessment, supporting content and construct validity. (Ditunno et
al., 2008).
Results Eighty-five percent of motor complete (66/78) and 10% (7/72) of
motor incomplete participants showed no progression (73/150). Of the
remaining participants (77/150) who improved, 81% (62/77) showed MDI.
However, the deviation from MDI occurred only at one timepoint in 10/15
participants. LEMS correlated with WISCI at initial and final assessment
(0.47 and 0.91 P<0.001). Parallel bar use differed between the US and
Europe possibly due to patterns of care. Use of braces also differed.

Convergent
Validity/
Reproducibility

Prospective study of 76 subjects with chronic SCI confirmed
convergent validity by correlating WISCI II levels to LEMS and walking
speed. Reproducibility was assessed with the intraclass correlation
coefficient (ICC) and the smallest real difference (SRD). (Burns et al.,
2011)
Results Convergent validity of the self-selected and maximum WISCI II with
LEMS was moderate for paraplegia (r = 0.479 and r = 0.533) and strong for
tetraplegia (r = 0.852 and r = 0.816). Tetraplegia, but not paraplegia,
demonstrated convergent validity of walking speed at the self-selected and
maximum WISCI levels with LEMS (r = 0.752 and r = 0.813). WISCI
reproducibility was excellent (Intraclass correlation (ICC) for self-selected
level 0.995). The resulting significant real differences (SRDs) of 0.785 (selfselected) and 0.597 (maximum), suggest that a change of one WISCI level can
be interpreted as real (meaningful) in a chronic patient.

Inter/Intra-rater
Reliability

Study of 26 subjects with chronic SCI from the United States and Italy
tested by two blinded raters on two separate
days to determine self-selected and maximum WISCI II levels and the
time to complete a 10-m walk confirmed inter.intra-rater reliability
(Marino et al., 2010).
Results Inter-and intra-rater reliability were 1.00 for self selected WISCI. The
intra-rater reliability for maximal level WISCI was 1.0; inter-rater reliability was
.98. The progression from self selected to maximal WISCI level also showed
high agreement between and within raters, with no communication between
therapists.

28

Walking Index for Spinal Cord Injury (WISCI II) Descriptors
Physical Limitation for walking secondary to impairment is defined at the person level and indicates the
ability of a person to walk after spinal cord injury. The development of this assessment index required
a rank ordering along a dimension of impairment, from the level of most severe impairment (0) to least
severe impairment (20) based on the use of devices, braces and physical assistance of one or more
persons. The order of the levels suggests each successive level is a less impaired level than the former.
The ranking of severity is based on the severity or the impairment and not on functional independence
in the environment. The following definitions standardize the terms used in each item:
Physical assistance:

‘Physical assistance of two persons’ is moderate to maximum assistance.
‘Physical assistance of one person’ is minimal to moderate assistance.
‘Contact guarding’ is minimal assistance

Braces:

‘Braces’ means one or two braces, either short or long leg.
(Splinting of lower extremities for standing is considered long leg bracing).
‘No braces’ means no braces on either leg.

Walker:

‘Walker’ is a conventional rigid walker without wheels.

Crutches:

‘Crutches’ can be Lofstrand (Canadian) or axillary.

Cane:

‘Cane’ is a conventional straight cane.

Level Description
0
1
meters
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Unable to stand and/or participate in assisted walking.
Ambulates in parallel bars, with braces and physical assistance of two persons, but less than 10
Ambulates in parallel bars, with braces and physical assistance of two persons, 10 meters.
Ambulates in parallel bars, with braces and physical assistance of one person, 10 meters.
Ambulates in parallel bars, no braces and physical assistance of one person, 10 meters
Ambulates in parallel bars, with no braces and no physical assistance, 10 meters.
Ambulates with walker, with braces and physical assistance of one person, 10 meters.
Ambulates with two crutches, with braces and physical assistance of one person, 10 meters.
Ambulates with walker, no braces and physical assistance of one person, 10 meters.
Ambulates with walker, with braces and no physical assistance, 10 meters.
Ambulates with one cane/crutch, with braces and physical assistance of one person, 10 meters.
Ambulates with two crutches, no braces and physical assistance of one person, 10 meters.
Ambulates with two crutches, with braces and no physical assistance, 10 meters.
Ambulates with walker, no braces and no physical assistance, 10 meters.
Ambulates with one cane/crutch, no braces and physical assistance of one person, 10 meters.
Ambulates with one cane/crutch, with braces and no physical assistance, 10 meters.
Ambulates with two crutches, no braces and no physical assistance, 10 meters.
Ambulates with no devices, no braces and physical assistance of one person, 10 meters.
Ambulates with no devices, with braces and no physical assistance, 10 meters.
Ambulates with one cane/crutch, no braces and no physical assistance, 10 meters.
Ambulates with no devices, no braces and no physical assistance, 10 meters.

Scoring Sheet for the Walking Index for Spinal Cord Injury II (WISCI II)
Name_____________________________________

Date_____________________

Check descriptors that apply to current walking performance, and then assign the highest level of
walking performance. (In scoring a level, one should choose the level at which the patient is safe
as judged by the therapist, with patient’s comfort level described. If devices other than those
stated in the standard definitions are used, they should be documented as descriptors. If there is a
discrepancy between two observers, the higher level should be chosen.)

Descriptors: Make ONE selection only in each section
Devices

Comments

D1 Parallel bars < 10 meters
D2 Parallel bars 10+ meters
D3 Walker - Standard
D4 Walker - rolling platform
D5 Walker – other > describe >>>
D6 Crutches - Uses 2
D7 Crutches - Uses 1
D8 Canes- Quad - Uses 2
D9 Canes- Quad - Uses 1
D10 No devices
Assistance
A1 Max assist x 2 people*
A2 Min/Mod assist x 2 people*
A3 Min/Mod assist x 1 personŧ
A4 No assistance

Braces
B1
B2
B3
B4
B5
B6
B7
B8
B9

Long Leg Braces - Uses 2 – Locked at knee
Long Leg Braces - Uses 1 - Locked at knee
Short Leg Braces - Uses 2 – Unlocked
Short Leg Braces - Uses 1 – Unlocked
Alpine boots
Ace bandages
High tops
Other braces / bracing methods > describe >
No braces

C1
C2
C3
C4

Patient reported comfort level
Very comfortable
Slightly comfortable
Neither comfortable nor uncomfortable
Slightly uncomfortable

Comments

Patient safety comments
*Applies only to WISCI II levels 1 and 2; ŧApplies to WISCI II levels 3,4,6,7,8,10,11,14,17

WISCI Levels
Level
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Devices

Braces

Assistance

Parallel bars
Parallel bars
Parallel bars
Parallel bars
Parallel bars
Walker
Two crutches
Walker
Walker
One cane/crutch
Two crutches
Two crutches
Walker
One cane/crutch
One cane/crutch
Two crutches
No devices
No devices
One cane/crutch
No devices

Braces
Braces
Braces
No braces
Braces
Braces
Braces
No braces
Braces
Braces
No braces
Braces
No braces
No braces
Braces
No braces
No braces
Braces
No braces
No braces

2 persons
2 persons
1 person
1 person
No assistance
1 person
1 person
1 person
No assistance
1 person
1 person
No assistance
No assistance
1 person
No assistance
No assistance
1 person
No assistance
No assistance
No assistance

Distance
Unable
Less than 10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters
10 meters

Baseline/Self-Selected Level assigned____________
Maximum WISCI Level assigned____________

Comments

Comments

